Canine adenovirus downstream processing protocol

Methods in Molecular Biology

Volumn 1089, Issue , 2014, Pages 197-210

  Puig, Meritxell ^a   Piedra, Jose ^a   Miravet, Susana ^a   Segura, María Mercedes ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CAV 2 vectors; Chromatography; Membrane filtration; Purification

Indexed keywords

2 DIETHYLAMINOETHANOL; ADENOVIRUS VECTOR; NUCLEIC ACID; RECOMBINANT VACCINE;

ANION EXCHANGE; ARTICLE; CANINE ADENOVIRUS; CANINE ADENOVIRUS TYPE 2; CHROMATOGRAPHY; CONDUCTANCE; DIAFILTRATION; DOWNSTREAM PROCESSING; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MICROFILTRATION; NONHUMAN; ONCOLYTIC VIROTHERAPY; PH; PRIORITY JOURNAL; PURIFICATION; ULTRAFILTRATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CAPSID;

ADENOVIRIDAE; CANINE ADENOVIRUS; CANINE ADENOVIRUS TYPE 2; CHICKEN ANEMIA VIRUS; HUMAN ADENOVIRUS; MIRIDAE;

ADENOVIRUSES, CANINE; ANIMALS; CELL LINE; CHROMATOGRAPHY; DOGS; FILTRATION; GENETIC VECTORS; HUMANS;

EID: 84934439444     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-679-5_14     Document Type: Article

References (21)

1. Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R et al (2003) Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol 41:5046-5052
2. Aste-Amezaga M, Bett AJ, Wang F, Casimiro DR, Antonello JM, Patel DK et al (2004) Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum Gene Ther 15:293-304
3. Bru T, Salinas S, Kremer EJ (2010) An update on canine adenovirus type 2 and its vectors. Viruses 2:2134-2153
4. Soudais C, Laplace-Builhe C, Kissa K, Kremer EJ (2001) Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo. FASEB J 15:2283-2285
5. Peltekian E, Garcia L, Danos O (2002) Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther 5:25-32
6. Alcayaga-Miranda F, Cascallo M, Rojas JJ, Pastor J, Alemany R (2010) Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies. Cancer Gene Ther 17:792-802
7. Smith BF, Curiel DT, Ternovoi VV, Borovjagin AV, Baker HJ, Cox N et al (2006) Administration of a conditionally replicative oncolytic canine adenovirus in normal dogs. Cancer Biother Radiopharm 21:601-606
8. Hemminki A, Kanerva A, Kremer EJ, Bauerschmitz GJ, Smith BF, Liu B et al (2003) A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model. Mol Ther 7:163-173
9. Bouet-Cararo C, Contreras V, Fournier A, Jallet C, Guibert JM, Dubois E et al (2011) Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep. Vaccine 29:1304-1310
10. Henderson H, Jackson F, Bean K, Panasuk B, Niezgoda M, Slate D et al (2009) Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Vaccine 27:7194-7197
11. Hu R, Zhang S, Fooks AR, Yuan H, Liu Y, Li H et al (2006) Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect 8:1090-1097
12. Hu RL, Liu Y, Zhang SF, Zhang F, Fooks AR (2007) Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25:5301-5307
13. Liu Y, Zhang S, Ma G, Zhang F, Hu R (2008) Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Vaccine 26:5368-5372
14. Dormond E, Perrier M, Kamen A (2009) From the first to the third generation adenoviral vector: what parameters are governing the production yield? Biotechnol Adv 27:133-144
15. Fernandes P, Peixoto C, Santiago VM, Kremer EJ, Coroadinha AS, Alves PM (2013) Bioprocess development for canine adenovirus type 2 vectors. Gene Ther 20(4):353-360
16. Segura MM, Puig M, Monfar M, Chillon M (2012) Chromatography purification of canine adenoviral vectors. Hum Gene Ther Methods 23(3):182-197
17. Altaras NE, Aunins JG, Evans RK, Kamen A, Konz JO, Wolf JJ (2005) Production and formulation of adenovirus vectors. Adv Biochem Eng Biotechnol 99:193-260
18. Segura MM, Kamen AA, Garnier A (2011) Overview of current scalable methods for purification of viral vectors. Methods Mol Biol 737:89-116
19. Segura MM, Monfar M, Puig M, Mennechet F, Ibanes S, Chillon M (2010) A real-time PCR assay for quantification of canine adenoviral vectors. J Virol Methods 163:129-136
20. Tancevski I, Wehinger A, Patsch JR, Ritsch A (2006) In vivo application of adenoviral vectors purified by a Taqman Real Time PCR-supported chromatographic protocol. Int J Biol Macromol 39:77-82
21. Hutchins B (2002) Development of a reference material for characterizing adenovirus vectors. BioProcess J 1:25-29